文献速递流行病学与生物统计临床试验与 GCP

非洲COVID-19相关研究:国际临床试验注册平台横断面综述

COVID-19-related research in Africa: a cross-sectional review of the International Clinical Trial Registration Platform (ICTRP).
PubMed 文献 · Trials · 2021-10-07

本研究基于WHO国际临床试验注册平台(ICTRP)数据库,提取2020年3月1日至2021年7月15日注册的COVID-19相关研究进行横断面分析。共纳入9803项研究,其中仅456项(4%)在非洲开展,且约80%集中在埃及和南非,多为药物和生物制品试验。非洲COVID-19相关研究数量显著少于世界其他地区,可能影响当地防控措施的科学证据基础。

要点

  • 非洲仅占全球COVID-19相关注册研究的4%(456/9803项)。
  • 非洲研究以干预性为主(270项,59.2%),观察性研究184项(40.4%)。
  • 约80%的非洲研究集中在埃及和南非,多涉及药物和生物制品测试。

核心结论

  • 非洲大陆开展的COVID-19相关研究数量显著少于世界其他地区,可能影响当地防控措施的科学证据基础。
  • 需要本地资金支持、研究项目自主权以及南北合作来提升非洲的研究能力。

研究设计与样本

  • 横断面研究,基于WHO国际临床试验注册平台(ICTRP)数据库。
  • 提取2020年3月1日至2021年7月15日注册的COVID-19相关研究。
  • 共纳入9803项研究,排除2060条重复记录和686条无站点/国家记录。
  • 采用描述性分析呈现结果。

主要发现

  • ICTRP门户共列出12533项COVID-19相关研究,最终纳入9803项。
  • 9347项研究(96%)在非洲以外开展,仅456项(4%)在非洲大陆开展。
  • 非洲研究中,干预性研究270项(59.2%),观察性研究184项(40.4%)。
  • 约80%的非洲研究在埃及和南非开展,多涉及药物和生物制品测试。

临床怎么用

  • 提示非洲COVID-19防控决策可依据的本地注册研究证据有限。
  • 建议加强非洲本地研究资助、项目自主权和南北合作以填补证据缺口。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The declaration of the coronavirus disease (COVID-19), a pandemic in early 2020, has seen an upsurge in research globally to fill gaps in the epidemiology of the SARS-CoV-2 virus impact on health care and clinical management, as well as possible prevention and treatment modalities. Published literature on the different types of COVID-19 research conducted globally is varied and is particularly limited in Africa. This study sets out to describe the COVID-19-related research registered and conducted on the African continent. METHODS: This is a cross-sectional study of all COVID-19-related studies available in the WHO's International Clinical Trials Registry Platform (ICTRP) repository. We extracted studies registered from March 1, 2020, to July 15, 2021. A descriptive analysis of the extracted data was performed, and the findings were presented. RESULTS: At extraction, a total of 12,533 COVID-19-related studies were listed on the ICTRP portal. We included 9803 studies, after excluding 2060 duplicate records and 686 records without a site/country. While 9347 studies (96%) were conducted outside of Africa, only 456 studies (4%) were conducted in the African continent, of which 270 (59.2%) were interventional studies, and 184 (40.4%) were observational studies. About 80% of the studies were conducted in Egypt and South Africa, and most of these involved testing of drugs and biologicals. CONCLUSION: The African continent hosts considerably fewer COVID-19-related research compared to other parts of the world. This may have implications on scientific evidence available for implementing COVID-19 control efforts. There is, therefore, a need for local funding and ownership of research projects and north-south collaboration in research.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Edem B, Williams V, Onwuchekwa C, et al. COVID-19-related research in Africa: a cross-sectional review of the International Clinical Trial Registration Platform (ICTRP). Trials. 2021. PMID: 34620207. doi:10.1186/s13063-021-05621-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。